EPIDERMODYSPLASIA VERRUCIFORMIS

This adverse event was reported 168 times

These drugs are most commonly taken by patients reporting EPIDERMODYSPLASIA VERRUCIFORMIS:

# Drug Count
0 PREDNISONE 97
1 TACROLIMUS 85
2 TACROLIMUS EXTENDED-RELEASE CAPSULES 82
3 TACROLIMUS OINTMENT 0.1% 82
4 MYCOPHENOLATE MOFETIL 76
5 AZATHIOPRINE 32
6 MYCOPHENILIC ACID 19
7 MYCOPHENOLIC ACID 19
8 CYCLOSPORINE 18
9 SIROLIMUS 16
See all common drugs associated with EPIDERMODYSPLASIA VERRUCIFORMIS

EPIDERMODYSPLASIA VERRUCIFORMIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SINECATECHINS 1 0.0185
1 IMIQUIMOD 6 0.0026
2 TAZAROTENE 2 0.0017
3 SIROLIMUS 16 0.0012
4 MYCOPHENILIC ACID 19 0.0009
5 CIDOFOVIR ANHYDROUS 1 0.0007
6 TACROLIMUS OINTMENT 0.1% 82 0.0006
7 TACROLIMUS EXTENDED-RELEASE CAPSULES 82 0.0006
8 EFAVIRENZ 7 0.0006
9 BELUMOSUDIL 2 0.0006
See all drugs enriched for association with EPIDERMODYSPLASIA VERRUCIFORMIS